Arcadia Biosciences CEO Rajendra Ketkar's 2018 pay jumps 40% to $904K

Arcadia Biosciences reports 2018 executive compensation

By ExecPay News

Published: April 18, 2019

Arcadia Biosciences reported fiscal year 2018 executive compensation information on April 18, 2019.
In 2018, four executives at Arcadia Biosciences received on average a compensation package of $626K, a 30% increase compared to previous year.
Average pay of disclosed executives at Arcadia Biosciences
Rajendra Ketkar, Chief Executive Officer, received $904K in total, which increased by 40% compared to 2017. 42% of Ketkar's compensation, or $384K, was in option awards. Ketkar also received $161K in non-equity incentive plan and $360K in salary.
Sarah Reiter, Chief Commercial Officer, received a compensation package of $783K. 65% of the compensation package, or $507K, was in option awards.
Matthew Plavan, Chief Financial Officer, earned $583K in 2018, a 20% increase compared to previous year.
Pamela Haley, Chief Financial Officer, received $234K in 2018.

Related executives

Rajendra Ketkar

Arcadia Biosciences

Chief Executive Officer

Matthew Plavan

Arcadia Biosciences

Chief Executive Officer

Sarah Reiter

Arcadia Biosciences

Former Chief Commercial Officer

Pamela Haley

Arcadia Biosciences

Chief Financial Officer

You may also like

Source: SEC filing on April 18, 2019.